NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 383 filers reported holding NEKTAR THERAPEUTICS in Q2 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $633,000 | +6.0% | 10,381 | -15.0% | 0.50% | +205.5% |
| Q2 2018 | $597,000 | -86.2% | 12,216 | -70.0% | 0.16% | -72.8% |
| Q1 2018 | $4,325,000 | +145.2% | 40,700 | +37.8% | 0.60% | +184.0% |
| Q4 2017 | $1,764,000 | +490.0% | 29,540 | +93.1% | 0.21% | +488.9% |
| Q2 2017 | $299,000 | -57.5% | 15,300 | -49.0% | 0.04% | -58.6% |
| Q1 2017 | $704,000 | +200.9% | 30,000 | +57.1% | 0.09% | +107.1% |
| Q4 2016 | $234,000 | – | 19,100 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |